OOIR: Observatory of International Research

Papers

(The H4-Index of Chest is 55. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)

Article	Citations
General Information	688
Monitoring Biologic Therapy in Asthma Using Functional Imaging	311
Effect of Corticosteroids on Long-Term Humoral and Memory T-Cell Responses in Follow-Up Visit of Hospitalized Patients With COVID-19	273
Keep Gimmicks of Toy E-Cigarettes Away and Juveniles on Track Towards the Tobacco Endgame	264
Intrafamilial Correlation and Variability in the Clinical Evolution of Pulmonary Fibrosis	235
General Information	201
Rebuttal From Drs Punjabi and Gottlieb	168
Table of Contents	166
Preprocedural COVID-19 Testing for High Risk Procedures	158
What Can Simulations Tell Us About Triage Protocols in a Real Pandemic?	157
Training POCUS	141
Response	129
Intrapleural Foreign Body in a Critically Ill Patient	128
Resilience in Health Care	118
A 49-Year-Old Woman With Persistent Bilateral Pleural Effusions	109
A 70-Year-Old Woman With Refractory Hypoxemia	107
General Information	91
General Information	88
Rebuttal From Dr Keir and Prof Chalmers	88
LACTOBACILLUS ENDOCARDITIS, A SINISTER CONSEQUENCE OF AN INNOCUOUS BACTERIUM	83
Response	83
A 36-Year-Old Patient With Crohn Disease and Bilateral Pleural Effusions	83
Comparison of Guidelines for Evaluation of Suspected Pulmonary Embolism in Pregnancy	82
“Suction vs Gravity: A Distinction Without a Difference?”	82
General Information	81

Point-of-Care Lung Ultrasound in Emergency Medicine	79
Chronic Cough-Related Differences in Brain Morphometry in Adults	78
Refining the Lung Allocation Score Models Fails to Improve Discrimination Performance	78
A DOUBLE HIT: PULMONARY ARTERIAL HYPERTENSION, BMPR2 MUTATION, AND EXPOSURE TO PRESCRIPTION AMPHETAMINES	77
ANGIOTENSIN II: A SALVAGE THERAPY IN CATECHOLAMINE-RESISTANT VASODILATORY SHOCK DUE TO CALCIUM CHANNEL BLOCKERS AND ACE INHIBITORS OVERDOSE	76
General Information	75
The Proton Is Not Enough	75
A 51-Year-Old Man With Dyspnea and a Pulmonary Nodule	75
Attic of Sorrow	71
REFRACTORY THROMBOTIC THROMBOCYTOPENIC PURPURA DUE TO COVID-19	71
Cancer in Cystic Fibrosis	71
SCREENING QUESTIONS AS AN EFFECTIVE PREDICTOR OF SMOKING CESSATION SUCCESS IN A SMOKING CESSATION PILOT PROGRAM	70
STUDYING THE LINK BETWEEN IDIOPATHIC PULMONARY FIBROSIS AND GI REFLUX DISEASE: A NATIONWIDE PERSPECTIVE	65
BENIGN PLEURAL SCHWANNOMA WITH PLEURAL EFFUSIONS AND NECROTIZING PNEUMONIA	65
CARDIAC TAMPONADE: BEYOND PERICARDIAL EFFUSION: A TALE OF TWO COMPRESSIVE MEDIASTINAL MASSES	64
REPERFUSION PULMONARY EDEMA AFTER RESECTION OF A MALIGNANT SOLITARY FIBROUS TUMOR OF THE PLEURA MANAGED WITH VENOVENOUS EXTRACORPOREAL MEMBRANE OXYGENATION	62
A RARE CASE OF SPONTANEOUS PNEUMOMEDIASTINUM DURING SECOND TRIMESTER OF PREGNANCY	62
NONCARDIOGENIC PULMONARY EDEMA IN AN OBESE PATIENT DUE TO EXCESSIVE DYNAMIC AIRWAY COLLAPSE AND SEVERE OSA	61
VARIABILITY IN CENTRAL AND LOCAL MEASUREMENT OF FVC IN IDIOPATHIC PULMONARY FIBROSIS: AN EXPLORATORY ANALYSIS FROM THE CAPACITY, ASCEND, AND RIFF (COHORT A) TRIALS	61
NONISCHEMIC CARDIOMYOPATHY PRESENTING WITH ABDOMINAL PAIN: AN INCIDENTAL LEFT VENTRICULAR THROMBUS	60
PROLACTINOMA PRECEDING SPORADIC LYMPHANGIOLEIOMYOMATOSIS: A CASE REPORT	60
WITHDRAWN	59
IMPORTANCE OF PATIENT THROUGHPUT WHEN SIMULATING CRISIS STANDARDS OF CARE: EXCLUSION CRITERIA AND TRIAGE SCORE MODIFIERS	59
HYDROCORTISONE, VITAMIN C, AND THIAMINE SUPPLEMENTATION VS PLACEBO IN PATIENTS WITH SEPSIS	58
TOXIC TO THE LUNGS: A CASE OF DAPTOMYCIN-INDUCED ACUTE EOSINOPHILIC PNEUMONIA	58
THIS DYSPNEA FEELS DIFFERENT: A CASE OF DIFFERENTIATION SYNDROME	57
NEW REFERENCE EQUATIONS FOR IMPULSE OSCILLOMETRY	57
AN UNUSUAL CAUSE OF RECURRENT PNEUMONIAS	57
A RARE CASE OF PACEMAKER LEAD-ASSOCIATED THROMBOSIS IN AN ANTICOAGULATED PATIENT	55
LONG-TERM FOLLOW UP OF CRYPTOGENIC FIBROSING PLEURISY IN A YOUNG WOMAN	55
CHRONIC MYELOID LEUKEMIA COMPLICATED WITH BILATERAL PLEURAL EFFUSIONS SECONDARY TO BOSUTINIB	55